Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project
Background and aim: Disease-modifying therapies (DMTs) used in multiple sclerosis (MS) have distinct safety profiles. In this paper, we report preliminary results of an on-going pharmacovigilance project (the FASM study). Results: Neurologists working at involved multiple sclerosis centers collected...
Main Authors: | Giorgia Teresa Maniscalco, Vincenzo Brescia Morra, Ciro Florio, Giacomo Lus, Gioacchino Tedeschi, Maddalena Cianfrani, Renato Docimo, Stefania Miniello, Felice Romano, Leonardo Sinisi, Daniele L. A. Spitaleri, Giuseppe Longo, Ugo Trama, Maria Triassi, FASM Group, Cristina Scavone, Annalisa Capuano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/12/466 |
Similar Items
-
Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
by: A. E. Krasheninnikov, et al.
Published: (2021-10-01) -
Preparation for the Inspection of the Pharmacovigilance System
by: B. K. Romanov
Published: (2021-10-01) -
Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01) -
Pharmacovigilance on cannabidiol as an antiepileptic agent
by: Ilaria Ammendolia, et al.
Published: (2023-02-01) -
Sex and gender differences and pharmacovigilance: a knot still to be untied
by: Liberata Sportiello, et al.
Published: (2024-04-01)